Jean-Pierre Macquet
About
In The Last Decade
Jean-Pierre Macquet
34 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 81
- Oncology 976
- Molecular Biology 699
- Organic Chemistry 657
- Materials Chemistry 250
- Electronic, Optical and Magnetic Materials 93
Countries citing papers authored by Jean-Pierre Macquet
This map shows the geographic impact of Jean-Pierre Macquet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean-Pierre Macquet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean-Pierre Macquet more than expected).
Fields of papers citing papers by Jean-Pierre Macquet
This network shows the impact of papers produced by Jean-Pierre Macquet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean-Pierre Macquet. The network helps show where Jean-Pierre Macquet may publish in the future.
Co-authorship network of co-authors of Jean-Pierre Macquet
This figure shows the co-authorship network connecting the top 25 collaborators of Jean-Pierre Macquet. A scholar is included among the top collaborators of Jean-Pierre Macquet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean-Pierre Macquet. Jean-Pierre Macquet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 22 | |
| 2 | 37 | |
| 3 | 3 | |
| 4 | Induction of polyploid nuclei in the plasmodium of Physarum polycephalum by platinum antitumor compounds. | 11 |
| 5 | 71 | |
| 6 | 18 | |
| 7 | A new highly water soluble platinum antitumor compound (phic) with lower toxicity and higher therapeutic index than cisplatin. Abstr. | 0 |
| 8 | 37 | |
| 9 | 114 | |
| 10 | 15 | |
| 11 | 1 | |
| 12 | 3 | |
| 13 | 144 | |
| 14 | 70 | |
| 15 | 104 | |
| 16 | 5 | |
| 17 | 5 | |
| 18 | 10 | |
| 19 | 9 | |
| 20 | 38 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.